Safety and Efficacy of Pharmacological Cardioversion of Recent Onset Atrial Fibrillation – A Single Centre Experience von Kriz, R, Freynhofer, M.K, Weiss, T.W, Egger, F.S, Gruber, S, Eisenburger, P, Wojta, J, Huber, K, Koch, J

Volltext

2190Prevalence, management and prognostic impact on long-term mortality of familial hypercholesterolemia in patients with acute or stable coronary artery disease von Tscharre, M., Herman, R., Rohla, M., Farhan, S., Tentzeris, I., Freynhofer, M.K., Weiss, T.W., Huber, K.

Volltext

P6227Prognostic impact of soluble p-selectin on long-term adverse cardiovascular outcome in patients with acute and stable coronary artery disease von Tscharre, M., Rohla, M., Tentzeris, I., Seper, M., Freynhofer, M.K., Vogel, B., Weiss, T.W., Ay, C., Huber, K., Farhan, S.

Volltext

Endogenous t‐PA‐antigen is an independent predictor of adverse cardiovascular events and all‐cause death in patients with atrial fibrillation von Freynhofer, M. K., Draxler, D. F., Gruber, S. C., Bruno, V., Höchtl, T., Fellner, B., Jakl‐Kotauschek, G., Wojta, J., Pabinger‐Fasching, I., Huber, K., Ay, C.

Volltext

Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus von Farhan, S., Tentzeris, I., Freynhofer, M.K., Vogel, B., Huber, K.

Volltext